Dov Gertzulin Portfolio: Top 5 Stocks

Page 5 of 5

1. United Therapeutics Corporation (NASDAQ:UTHR)

DG Capital Management’s Stake Value: $25.1 million
Percentage of DG Capital Management’s 13F Portfolio: 5.43%
Number of Hedge Fund Holders: 45

Coming in at first on our list of the top 10 stocks in Dov Gertzulin’s portfolio, United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company that is engaged in the manufacture of replacement organs and treatment for organ diseases.

Dov Gertzulin owns 140,299 shares in United Therapeutics Corporation (NASDAQ:UTHR), worth more than $25.1 million, representing 5.43% of his hedge fund’s investment portfolio. According to our database, 45 elite funds were bullish on the company at the end of June, up from 42 in the preceding quarter.

Jim Simons’ Renaissance Technologies is the leading shareholder in United Therapeutics Corporation (NASDAQ:UTHR), with over 3.1 million shares worth more than $557.9 million.

You can also take a look at 10 Stocks to Buy According to James Mitarotonda’s Barington Capital and Analysts are Cutting Price Targets of These 10 Stocks.

Page 5 of 5